Literature DB >> 8064228

The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy.

P Romagnoli1, R N Germain.   

Abstract

Invariant chain (Ii) contributes in a number of distinct ways to the proper functioning of major histocompatibility complex (MHC) class II molecules. These include promoting effective association and folding of newly synthesized MHC class II alpha and beta subunits, increasing transit of assembled heterodimers out of the endoplasmic reticulum (ER), inhibiting class II peptide binding, and facilitating class II movement to or accumulation in endosomes/lysosomes. Although the cytoplasmic tail of Ii makes a key contribution to the endocytic localization of class II, the relationship between the structure of Ii and its other diverse functions remains unknown. We show here that two thirds of the lumenal segment of Ii can be eliminated without affecting its contributions to the secretory pathway events of class II folding, ER to Golgi transport, or inhibition of peptide binding. These same experiments reveal that a short (25 residue) contiguous internal segment of Ii (the CLIP region), frequently found associated with purified MHC class II molecules, is critical for all three functions. Together with other recent findings, these results raise the possibility that the contributions of Ii to the early postsynthetic behavior of class II may depend on its interaction with the class II binding site. This would be consistent with the intracellular behavior of unoccupied MHC class I and class II molecules as incompletely folded proteins and imply a related structural basis for the similar contributions of Ii to class II and of short peptides to class I assembly and transport.

Mesh:

Substances:

Year:  1994        PMID: 8064228      PMCID: PMC2191661          DOI: 10.1084/jem.180.3.1107

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

Review 1.  MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.

Authors:  R N Germain
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

2.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.

Authors:  L J Stern; J H Brown; T S Jardetzky; J C Gorga; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

3.  HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells.

Authors:  S P Fling; B Arp; D Pious
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

4.  An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.

Authors:  P Morris; J Shaman; M Attaya; M Amaya; S Goodman; C Bergman; J J Monaco; E Mellins
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

5.  Ia invariant chain detected on lymphocyte surfaces by monoclonal antibody.

Authors:  N Koch; S Koch; G J Hämmerling
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

6.  Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells.

Authors:  C A Janeway; P J Conrad; E A Lerner; J Babich; P Wettstein; D B Murphy
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

7.  Mice lacking the MHC class II-associated invariant chain.

Authors:  S Viville; J Neefjes; V Lotteau; A Dierich; M Lemeur; H Ploegh; C Benoist; D Mathis
Journal:  Cell       Date:  1993-02-26       Impact factor: 41.582

8.  Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression.

Authors:  E K Bikoff; L Y Huang; V Episkopou; J van Meerwijk; R N Germain; E J Robertson
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

9.  The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules.

Authors:  E A Elliott; J R Drake; S Amigorena; J Elsemore; P Webster; I Mellman; R A Flavell
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

10.  Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain.

Authors:  C Bonnerot; M S Marks; P Cosson; E J Robertson; E K Bikoff; R N Germain; J S Bonifacino
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

View more
  57 in total

1.  Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.

Authors:  K Frauwirth; N Shastri
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM.

Authors:  J A Villadangos; C Driessen; G P Shi; H A Chapman; H L Ploegh
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

Review 3.  HLA-DM and the MHC class II antigen presentation pathway.

Authors:  P E Jensen; D A Weber; W P Thayer; X Chen; C T Dao
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

4.  PapD-like chaperones provide the missing information for folding of pilin proteins.

Authors:  M M Barnhart; J S Pinkner; G E Soto; F G Sauer; S Langermann; G Waksman; C Frieden; S J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  Invariant chain induces B cell maturation in a process that is independent of its chaperonic activity.

Authors:  Didi Matza; Frida Lantner; Yoel Bogoch; Liat Flaishon; Rami Hershkoviz; Idit Shachar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

6.  Is tapasin a modified Mhc class I molecule?

Authors:  W E Mayer; J Klein
Journal:  Immunogenetics       Date:  2001-12-18       Impact factor: 2.846

Review 7.  MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.

Authors:  Toine ten Broeke; Richard Wubbolts; Willem Stoorvogel
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

Review 8.  A peptide's perspective on antigen presentation to the immune system.

Authors:  Jacques Neefjes; Huib Ovaa
Journal:  Nat Chem Biol       Date:  2013-12       Impact factor: 15.040

9.  Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii.

Authors:  A Jasanoff; G Wagner; D C Wiley
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

10.  Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses.

Authors:  Marvin M van Luijn; Martine E D Chamuleau; James A Thompson; Suzanne Ostrand-Rosenberg; Theresia M Westers; Yuri Souwer; Gert J Ossenkoppele; S Marieke van Ham; Arjan A van de Loosdrecht
Journal:  Haematologica       Date:  2009-11-10       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.